Description
The Medicare Advantage market has seen unprecedented growth in recent years, with a majority of Medicare eligible beneficiaries enrolling in one of these privately administered plans in 2024. But over the past couple of years, the industry has experienced some growing pains—ranging from more regulatory scrutiny to higher costs associated with members utilizing more healthcare services.
In the second half of their conversation, Joyjit Saha Choudhury, Managing Director of the Kaufman Hall’s Strategy and Business Transformation practice, joins host J. Carlisle Larsen to talk about the potential worst-case scenario for the market.
You can find the first part of their conversation here.
Hosted on Acast. See acast.com/privacy for more information.
President-elect Trump taps former-TV personality Dr. Oz to lead the Centers for Medicare and Medicaid Services. The parent companies of major U.S. pharmacy benefit managers sue the Biden Administration over a recent suit brought by the FTC alleging that PBMS engage in anticompetitive rebate...
Published 11/22/24
Incoming President Donald Trump is reportedly weighing significant changes to Medicaid, and some states are rushing to get their waiver requests in before President Biden leaves office. UnitedHealth Group announces Change Healthcare’s clearinghouse services are fully operational following a...
Published 11/20/24